Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional botulinum toxin versus placebo in male androgenetic alopecia on finasteride
IRCT20191013045092N3Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in androgenetic alopecia (AGA) comparing Intralesional botulinum toxin + finasteride with Placebo intralesional injection + finasteride (2 arms). Started Jul 2022; status: completed.
02
Drugs
neuronox
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20191013045092N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191013045092N3.